Gmt Capital Corp Ironwood Pharmaceuticals Inc Transaction History

Gmt Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.32 - $15.45 $2.27 Million - $4.21 Million	-272,600 Reduced 76.49%	83,800 $729,000
Q4 2023 Feb 12, 2024	SELL	$8.79 - $11.51 $921,191 - $1.21 Million	-104,800 Reduced 22.72%	356,400 $4.08 Million
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $3.8 Million - $5.23 Million	461,200 New	461,200 $4.44 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Gmt Capital Corp with notifications on news.